Add Cs2CO3
(3.25 g, 10.0 mmol), followed by the chloromethylthiazole (2.60 g) to a
stirred solution of 4-mercapto-2-methylphenol (1.40 g) in CH3CN (80
mL). Stir the reaction mixture at room temperature for 4 hours. Add Cs2CO3
(4.89 g, 15.0 mmol), followed by methyl bromoacetate (1.23 mL, 13.0
mmol) to the mixture. Stir the reaction mixture at room temperature for
another 5 hours. Pour the mixture into water. Extract the mixture with
EtOAc (3 x 100 mL). Combine the organic layers. Wash the organic layers
with brine. Dry the organic layers (Na2SO4). Concentrate the organic layers. Purify the residue by column chromatography on silica gel with hexane/ ethyl acetate (5:1). 1H NMR (CDCl3)
δ7.97 (d, 2H, J= 8.4 Hz), 7.65 (d, 2H, J= 8.4 Hz), 7.21 (d, 1H, J= 2.4
Hz), 7.13 (dd, 1H, J= 8.4, 2.4 Hz), 6.58 (d, 1H, J= 8.4 Hz), 4.63 (s,
2H), 4.11 (s, 2H), 3.78 (s, 3H), 2.24 (s, 3H), 2.20 (s, 3H). 13C NMR (CDCl3)
δ169.2, 163.0, 156.3, 151.3, 136.8, 136.1, 132.1, 131.2 (q, J= 32 Hz),
130.6, 128.4, 126.3, 125.8 (q, J= 4 Hz), 125.3, 122.1, 111.4, 65.4,
52.2, 32.4, 16.1, 14.8. 19F NMR (CDCl3) δ115.5 (s).
Fig. The synthetic step 1 of GW-501516